venBio Global Strategic GP II, Ltd., 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI), sold 541,350 shares at $10.38 ($5.6M) on 2022-05-02, disclosed to the SEC on 2022-05-04.
Open-market sale of $5.6M CMPI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.38 | 153,700 | $1.6M | 28.4% |
| 2 | $10.38 | 153,700 | $1.6M | 28.4% |
| 3 | $10.37 | 79,475 | $824K | 14.7% |
| 4 | $10.37 | 79,475 | $824K | 14.7% |
| 5 | $10.37 | 37,500 | $389K | 6.9% |
| 6 | $10.37 | 37,500 |
| $389K |
| 6.9% |
| Total | $10.38 avg | 541,350 | $5.6M | 100% |
| Filing → |
| AKRO | BUY | 2019-06-25 | $4.0M | — | Filing → |